Get Afrezza for as Low as $4 a Day
This content originally appeared on TCOYD: Taking Control of Your Diabetes. Republished with permission.Innovative Cash Program Afrezza is a rapid-acting inhaled insulin indicated to improve glycemic control in adult patients with diabetes mellitus. MannKind Corporation, makers of Afrezza, just announced a direct purchase program to help those with diabetes obtain this medication for as little as $4 […]
Source: diabetesdaily.com